Cost-benefit of self-prescribing

Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.

Journal of public health (Oxford, England)·2009

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines.

Health technology assessment (Winchester, England)·2007

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

British journal of clinical pharmacology·2007

Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence.

Human reproduction (Oxford, England)·2005

Proton pump inhibitors: perspectives of patients and their GPs.

The British journal of general practice : the journal of the Royal College of General Practitioners·2001

The rise and rise of proton pump inhibitor drugs: patients' perspectives.

Social science & medicine (1982)·1997

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2025.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Opioid Use in Children.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026

Designing Implementable Deprescribing Recommendations: A Qualitative Study of Healthcare Professional Perspectives.

Journal of general internal medicine·2026

Non-prescription antibiotic dispensing in community pharmacies in jordan: a simulated patient study.

The Libyan journal of medicine·2026

Barriers to Electronic Prescription Circulation Under Employee Medical Insurance Outpatient Coordination: Evidence from a Pilot City in China.

Risk management and healthcare policy·2026

Paramedic perspectives on prehospital buprenorphine: A qualitative case study of implementation in emergency medical services.

The American journal of emergency medicine·2026

Related Experiment Videos

Cost-benefit of self-prescribing

Related Concept Videos

Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines.

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence.

Proton pump inhibitors: perspectives of patients and their GPs.

The rise and rise of proton pump inhibitor drugs: patients' perspectives.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2025.

Opioid Use in Children.

Designing Implementable Deprescribing Recommendations: A Qualitative Study of Healthcare Professional Perspectives.

Non-prescription antibiotic dispensing in community pharmacies in jordan: a simulated patient study.

Barriers to Electronic Prescription Circulation Under Employee Medical Insurance Outpatient Coordination: Evidence from a Pilot City in China.

Paramedic perspectives on prehospital buprenorphine: A qualitative case study of implementation in emergency medical services.

Related Experiment Videos

Cost-benefit of self-prescribing

Related Concept Videos

Related Articles